Bank of New York Mellon’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,106
Closed -$55K 4269
2014
Q4
$55K Sell
2,106
-1,818
-46% -$39.9K ﹤0.01% 4135
2014
Q3
$70K Buy
+3,924
New +$80.1K ﹤0.01% 4125
2014
Q2
Sell
-1,262
Closed -$32K 4240
2014
Q1
$32K Buy
+1,262
New +$34.9K ﹤0.01% 4125

Other funds holding PGEN

Bank of New York Mellon's PGEN Position: Q2 2026 in Review

Bank of New York Mellon increased its Precigen (PGEN) stake by 9.5% in Q2 2026, buying an estimated $178K and bringing the position to 474,497 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2774.

Bank of New York Mellon first reported a position in PGEN in Q3 2013 and has held it in 51 quarters since. The position peaked at $10.2M in Q1 2015. 116 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Bank of New York Mellon held 474,497 shares of Precigen worth $2.7M as of Q2 2026.
  • Bank of New York Mellon bought 41,190 Precigen shares in Q2 2026, an estimated $178K.
  • Precigen made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2774 holding.
  • Bank of New York Mellon first reported a position in Precigen in Q3 2013 and has held it in 51 quarters since.
  • Bank of New York Mellon's Precigen position peaked at $10.2M in Q1 2015.
  • 116 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.